Cytek Biosciences, Inc. (CTKB) Misses Q1 EPS by 7c, Misses on Revenue; Offers FY25 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: CTKB) | Delayed: 5.94 +0.05 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.89 | 52 Week High | $ | |||
| Open | $5.89 | 52 Week Low | $ | |||
| Day High | $6.01 | P/E | N/A | |||
| Day Low | $5.80 | EPS | $ | |||
| Volume | 561,910 | |||||
